ANDEMBRY 200 mg/1.2mL
Garadacimab · INJECTION, SOLUTION · CSL
No Recall History
Plain English
ANDEMBRY is a injection, solution containing garadacimab at 200 mg/1.2mL, taken subcutaneous. Manufactured by CSL.
Key Facts
- Brand Name
- ANDEMBRY
- Generic Name
- Garadacimab
- NDC Code (Product)
63833-925- Manufacturer
- CSL
- Strength
- 200 mg/1.2mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761367
- Marketing Start
- 06/16/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is ANDEMBRY used for?
ANDEMBRY contains Garadacimab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is ANDEMBRY a controlled substance?
ANDEMBRY is not classified as a controlled substance by the DEA.
What is the generic name for ANDEMBRY?
The generic name for ANDEMBRY is Garadacimab. There are no other listed brand versions of Garadacimab.
What is the NDC code for ANDEMBRY 200 mg/1.2mL?
The NDC (National Drug Code) for ANDEMBRY 200 mg/1.2mL is 63833-925, listed by CSL.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)